My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial.

    Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Gans RO, van Ballegooie E, Bilo HJ.

    Diabetes Care. 2009 Aug;32(8):1372-7. Epub 2009 May 8.PMID: 19429874 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

    DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

    Diabetes Care. 2002 Nov;25(11):2074-80.PMID: 12401759 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study.

    Logtenberg SJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ.

    Diabetes Technol Ther. 2009 May;11(5):293-9.PMID: 19425877 [PubMed - indexed for MEDLINE]Related articles

    4.

    Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

    Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

    Diabetes Technol Ther. 2005 Aug;7(4):587-96.PMID: 16120030 [PubMed - indexed for MEDLINE]Related articles

    5.

    Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

    Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B.

    Diabetes Care. 2004 Nov;27(11):2590-6.PMID: 15504991 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

    Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

    Diabetes Technol Ther. 2007 Aug;9(4):339-47.PMID: 17705689 [PubMed - indexed for MEDLINE]Related articles

    7.

    Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.

    Weintrob N, Schechter A, Benzaquen H, Shalitin S, Lilos P, Galatzer A, Phillip M.

    Arch Pediatr Adolesc Med. 2004 Jul;158(7):677-84.PMID: 15237068 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term safety and efficacy of programmable implantable insulin delivery systems.

    Olsen CL, Liu G, Iravani M, Nguyen S, Khourdadjian K, Turner DS, Waxman K, Selam JL, Charles MA.

    Int J Artif Organs. 1993 Dec;16(12):847-54.PMID: 8175202 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

    Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

    Diabetes Care. 2009 Jul;32(7):1170-6. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944. PMID: 19389820 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

    Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

    Clin Ther. 2007 Nov;29(11):2374-84.PMID: 18158078 [PubMed - indexed for MEDLINE]Related articles

    11.

    Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

    Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

    Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.

    Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC; Inhaled Insulin Phase III Type 1 Diabetes Study Group.

    Diabetes Care. 2005 Jul;28(7):1630-5.PMID: 15983312 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

    Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M.

    Pediatrics. 2003 Sep;112(3 Pt 1):559-64.PMID: 12949284 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

    Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

    Diabetes Care. 2005 Jul;28(7):1568-73.PMID: 15983302 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.

    Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA.

    Diabetes Technol Ther. 2008 Oct;10(5):377-83.PMID: 18715214 [PubMed - indexed for MEDLINE]Related articles

    16.

    Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.

    Saudek CD, Duckworth WC, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA.

    JAMA. 1996 Oct 23-30;276(16):1322-7.PMID: 8861991 [PubMed - indexed for MEDLINE]Related articles

    17.

    Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

    Bode BW, Steed RD, Schleusener DS, Strange P.

    Endocr Pract. 2005 May-Jun;11(3):157-64.PMID: 16239201 [PubMed - indexed for MEDLINE]Related articles

    18.

    Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion.

    Oskarsson PR, Lins PE, Wallberg Henriksson H, Adamson UC.

    Diabetes Metab. 1999 Dec;25(6):491-7.PMID: 10633873 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.

    Diabetes Care. 2000 Sep;23(9):1232-5.PMID: 10977011 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity